BioMediTech at the University of Tampere (UTA) is part of the joint BioMediTech institute of the UTA and Tampere University of Technology (TUT).
BioMediTech is a joint institute of the University of Tampere (UTA) and Tampere University of Technology (TUT). Its research activities cover diverse areas, including cell and molecular biology, genetics, biomaterials, biosensors, computational systems, biotechnology, biomedical engineering, and regenerative medicine.
At BioMediTech, UTA and TUT educate together top-level experts with multidisciplinary skills in life sciences for the demands of both academia and industry. The students apply to and their studies are administered by either UTA or TUT.
These pages concentrate on the BioMediTech activities administered by the University of Tampere. The issues concerning the joint institute can be found on the institute's webpages.
Demyelinating diseases, such as multiple sclerosis (MS), cause increased morbidity and mortality to a huge amount of people worldwide. BioMediTech researchers are working for developing better medication and also for better understanding of the pathology in MS and other demyelinating diseases.